The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials.

The journal of headache and pain 20120601

Implication of free cholesterol in LC-MS response enhancement.

Bioanalysis 20120601

Taking the negative view of current migraine treatments: the unmet needs.

CNS drugs 20120501

Italian guidelines for primary headaches: 2012 revised version.

The journal of headache and pain 20120501

Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20120501

Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized study.

Headache 20120401

Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.

Headache 20120101

Rescue therapy for acute migraine, part 1: triptans, dihydroergotamine, and magnesium.

Headache 20120101

Subcutaneous delivery of sumatriptan in the treatment of migraine and primary headache.

Patient preference and adherence 20120101

Sumatriptan (intranasal route of administration) for acute migraine attacks in adults.

The Cochrane database of systematic reviews 20120101

Headache in pregnancy: a nuisance or a new sense?

Obstetrics and gynecology international 20120101

Two chromatographic methods for the determination of some antimigraine drugs.

Analytical chemistry insights 20120101

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.

The journal of headache and pain 20111201

Suggested randomised, controlled trial with frovatriptan.

The journal of headache and pain 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

An approach for rapid development of nasal delivery of analgesics--identification of relevant features, in vitro screening and in vivo verification.

International journal of pharmaceutics 20111125

Are menstrual and nonmenstrual migraine attacks different?

Current pain and headache reports 20111001

CONSORT recommendations in abstracts of randomised, controlled trials on migraine and headache.

The journal of headache and pain 20111001

Types of colitis based on histology.

Disease-a-month : DM 20110901

Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register.

The journal of headache and pain 20110801

Guidelines on the diagnosis and the current management of headache and related disorders.

Annals of Indian Academy of Neurology 20110701

Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment.

The journal of headache and pain 20110601

A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine.

The journal of headache and pain 20110601

When to use frovatriptan in migraine?

The journal of headache and pain 20110601

Evolution of paediatric off-label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994-2007.

British journal of clinical pharmacology 20110601

Triptan overuse in the Dutch general population: a nationwide pharmaco-epidemiology database analysis in 6.7 million people.

Cephalalgia : an international journal of headache 20110601

Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.

Cephalalgia : an international journal of headache 20110501

Rizatriptan is effective for headache in a patient with meningeal carcinomatosis.

Journal of pain and symptom management 20110501

Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110501

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110501

A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine.

The journal of headache and pain 20110401

Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische Kopfschmerzgesellschaft (ÖKSG) and the Schweizerische Kopfwehgesellschaft (SKG).

The journal of headache and pain 20110401

Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database.

Headache 20110301

Triptans other than sumatriptan in child and adolescent migraine: literature review.

Expert review of neurotherapeutics 20110301

Rizatriptan reduces vestibular-induced motion sickness in migraineurs.

The journal of headache and pain 20110201

Why pharmacokinetic differences among oral triptans have little clinical importance: a comment.

The journal of headache and pain 20110201

Acute migraine therapy: new drugs and new approaches.

Current treatment options in neurology 20110201

Overview of diagnosis and management of paediatric headache. Part II: therapeutic management.

The journal of headache and pain 20110201

Nociceptive behaviors were induced by electrical stimulation of the dura mater surrounding the superior sagittal sinus in conscious adult rats and reduced by morphine and rizatriptan benzoate.

Brain research 20110112

The Fos expression in rat brain following electrical stimulation of dura mater surrounding the superior sagittal sinus changed with the pre-treatment of rizatriptan benzoate.

Brain research 20110107

Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migraine.

Headache 20110101

Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial.

Headache 20110101

Combined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics?

BMC neurology 20110101

Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review.

Journal of pharmacy & bioallied sciences 20110101

Formulation, In Vitro and In Vivo Pharmacokinetics of Anti-HIV Vaginal Bioadhesive Gel.

Journal of young pharmacists : JYP 20110101

Migraine attacks the Basal Ganglia.

Molecular pain 20110101

Efficacy of parecoxib, sumatriptan, and rizatriptan in the treatment of acute migraine attacks.

Clinical neuropharmacology 20110101

A large pharmacy claims-based descriptive analysis of patients with migraine and associated pharmacologic treatment patterns.

Neuropsychiatric disease and treatment 20110101

The use of triptans for pediatric migraines.

Paediatric drugs 20101201

4-[3-(1H-Imidazol-1-yl)prop-yl]-3-methyl-5-(thio-phen-2-ylmeth-yl)-4H-1,2,4-triazole monohydrate.

Acta crystallographica. Section E, Structure reports online 20101201

Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20101001

Prevention and treatment of menstrual migraine.

Drugs 20101001

Triptans for the management of migraine.

Drugs 20100820

Brain apparent water diffusion coefficient magnetic resonance image during a prolonged visual aura.

Headache 20100601

Arterial spin-labeled MRI study of migraine attacks treated with rizatriptan.

The journal of headache and pain 20100601

New acute treatments for headache.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20100601

Omega-3 fatty acids in the maintenance of ulcerative colitis.

JRSM short reports 20100601

Prescribing for migraine with the focus on selective 5HT1-receptor agonists: a pharmacy database analysis.

International journal of clinical pharmacology and therapeutics 20100501

Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study.

Headache 20100401

Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis.

Expert review of neurotherapeutics 20100401

Acute management of migraine.

The Journal of the Association of Physicians of India 20100401

Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled Trial.

Journal of clinical neurology (Seoul, Korea) 20100301

Entry demographics and pharmacological treatment of migraine patients referred to a tertiary care pain clinic.

Cephalalgia : an international journal of headache 20100101

A study of triggers of migraine in India.

Pain medicine (Malden, Mass.) 20100101

Formulation and evaluation of rizatriptan benzoate mouth disintegrating tablets.

Indian journal of pharmaceutical sciences 20100101

[Update on current care guidelines; childhood headache].

Duodecim; laaketieteellinen aikakauskirja 20100101

Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.

BMJ (Clinical research ed.) 20100101

Drug interaction and pharmacist.

Journal of young pharmacists : JYP 20100101

Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies.

BMC family practice 20100101

Synesthesia and migraine: case report.

BMC neurology 20100101

Development and Validation of HPTLC Method for the Estimation of Rizatriptan Benzoate in Bulk and Tablets.

Indian journal of pharmaceutical sciences 20100101

Extreme thermal sensitivity and pain-induced sensitization in a fibromyalgia patient.

Pain research and treatment 20100101

The role of funding and policies on innovation in cancer drug development.

Ecancermedicalscience 20100101

Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.

Headache 20091001

Rizatriptan induced acute on top of chronic ischemic colitis.

The American journal of gastroenterology 20091001

A comparison of migraine patients with and without allodynic symptoms.

The Clinical journal of pain 20091001

4-Amino-3-[(4-methoxy-phen-yl)amino-meth-yl]-1H-1,2,4-triazole-5(4H)-thione.

Acta crystallographica. Section E, Structure reports online 20090901

4-Amino-3-(o-tolyl-oxymeth-yl)-1H-1,2,4-triazole-5(4H)-thione.

Acta crystallographica. Section E, Structure reports online 20090801

4-Amino-3-(p-tolyl-oxymeth-yl)-1H-1,2,4-triazole-5(4H)-thione.

Acta crystallographica. Section E, Structure reports online 20090801

Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults.

Cephalalgia : an international journal of headache 20090701

5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials.

Journal of clinical medicine research 20090601

Migraine treatment with rizatriptan and almotriptan: a crossover study.

Headache 20090501

Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response.

Headache 20090501

[Utilizing the strength(s) of rizatriptan 10 mg: cost effective against migraine attacks].

MMW Fortschritte der Medizin 20090326

Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis.

Headache 20090301

Perimenstrual headache: treatment options.

Current pain and headache reports 20090201

10 years of rizatriptan.

Headache 20090201

Ten years of rizatriptan: from development to clinical science and future directions.

Headache 20090201

Acute migraine treatment with rizatriptan in real world settings - focusing on treatment strategy, effectiveness, and behavior.

Headache 20090201

Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.

Journal of pharmaceutical and biomedical analysis 20090115

Identification of aquaporin 4 inhibitors using in vitro and in silico methods.

Bioorganic & medicinal chemistry 20090101

Alcohol and cluster headaches.

Headache 20090101

Individual triptan selection in migraine attack therapy.

Recent patents on CNS drug discovery 20090101

Systematic review on quality control for drug management programs: is quality reported in the literature?

BMC health services research 20090101

A pilot study of rizatriptan and visually-induced motion sickness in migraineurs.

International journal of medical sciences 20090101

Expanding access to triptans: assessment of clinical outcome.

Headache 20090101

Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life.

Patient preference and adherence 20090101

Pediatric migraine.

International journal of pediatrics 20090101

Recent advances in the pharmacological management of migraine.

F1000 medicine reports 20090101

Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan.

International journal of clinical practice 20081201

Current migraine management - patient acceptability and future approaches.

Neuropsychiatric disease and treatment 20081201

Prophylaxis of migraine: general principles and patient acceptance.

Neuropsychiatric disease and treatment 20081201

Elastic liposomal formulation for sustained delivery of antimigraine drug: in vitro characterization and biological evaluation.

Drug development and industrial pharmacy 20081001

A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine.

Headache 20081001

Optimizing prophylactic treatment of migraine: Subtypes and patient matching.

Therapeutics and clinical risk management 20081001

Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.

Headache 20080901

Effects of rizatriptan on the contingent negative variation in healthy women.

Cephalalgia : an international journal of headache 20080901

Indolealkylamines: biotransformations and potential drug-drug interactions.

The AAPS journal 20080601

Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.

Headache 20080601

Management of migraine in adolescents.

Neuropsychiatric disease and treatment 20080601

Treatment of children with migraine in the emergency department: a qualitative systematic review.

Pediatric emergency care 20080501

Acute treatment and prevention of menstrually related migraine headache: evidence-based review.

Neurology 20080422

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine.

Neurology 20080415

Use of 5-HT1 agonists in pregnancy.

The Annals of pharmacotherapy 20080401

A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future.

Expert opinion on pharmacotherapy 20080401

[A new therapeutic principle for migraine].

Ugeskrift for laeger 20080317

Traditional acupuncture in migraine: a controlled, randomized study.

Headache 20080301

Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.

Headache 20080301

Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.

Headache 20080201

Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.

Headache 20080201

Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.

The journal of headache and pain 20080201

Triptans in pregnancy.

Therapeutic drug monitoring 20080201

Acute treatment of paediatric migraine: a meta-analysis of efficacy.

Journal of paediatrics and child health 20080101

Almotriptan, an antimigraine agent, and its malate salt.

Acta crystallographica. Section C, Crystal structure communications 20080101

Almotriptan in the treatment of migraine.

Neuropsychiatric disease and treatment 20071201

Pediatric vestibulopathy and pseudovestibulopathy: differential diagnosis and management.

Current opinion in otolaryngology & head and neck surgery 20071001

Triptans in the treatment of migraine: drug selection by means of the SOJA method.

Expert opinion on pharmacotherapy 20071001

Osteoporosis medication profile preference: results from the PREFER-US study.

Health expectations : an international journal of public participation in health care and health policy 20070901

Symptoms of cutaneous sensitivity pre-treatment and post-treatment: results from the rizatriptan TAME studies.

Cephalalgia : an international journal of headache 20070901

Treatment of hemiplegic migraine with triptans.

European journal of neurology 20070901

Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.

Headache 20070901

Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study.

International journal of clinical practice 20070801

Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.

Pharmacotherapy 20070801

WITHDRAWN: Rizatriptan for acute migraine.

The Cochrane database of systematic reviews 20070718

Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans.

International journal of clinical practice 20070701

Uptake and biodistribution of rizatriptan to blood and brain following different routes of administration in rats.

International journal of pharmaceutics 20070607

Association study between clinical response to rizatriptan and some candidate genes.

The journal of headache and pain 20070601

Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial.

The journal of headache and pain 20070601

Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine.

Headache 20070601

Acute migraine: Current treatment and emerging therapies.

Therapeutics and clinical risk management 20070601

[Bonus-malus regulations in the framework of the AVWG guideline-suitable migraine therapy are possible].

MMW Fortschritte der Medizin 20070521

Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.

Cephalalgia : an international journal of headache 20070501

Investigation of low levels of plasma valproic acid concentration following simultaneous administration of sodium valproate and rizatriptan benzoate.

The Journal of pharmacy and pharmacology 20070301

Comment on eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.

Headache 20070301

Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan.

Journal of neurology 20070201

Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine.

CNS drugs 20070101

The cost-effectiveness of oral triptan therapy in Sweden.

Cephalalgia : an international journal of headache 20070101

Simultaneous determination of amiloride and hydrochlorothiazide in human plasma by liquid chromatography/tandem mass spectrometry with positive/negative ion-switching electrospray ionisation.

Rapid communications in mass spectrometry : RCM 20070101

Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study.

BMC clinical pharmacology 20070101

Development and validation of a selective and robust LC-MS/MS method for high-throughput quantifying rizatriptan in small plasma samples: application to a clinical pharmacokinetic study.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061205

Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments.

Expert opinion on drug metabolism & toxicology 20061201

A pharmacoeconomic evaluation of oral triptans in the treatment of migraine in Italy.

Minerva medica 20061201

A review of evidence-based medicine and meta-analytic reviews in migraine.

Cephalalgia : an international journal of headache 20061101

Transient ischemic attack after rizatriptan administration in a liver transplant recipient: a case report.

Transplantation proceedings 20061101

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20061101

Increasing the effect of triptans in migraine.

Lancet (London, England) 20061014

A randomized trial of rizatriptan in migraine attacks in children.

Neurology 20061010

A review of diagnostic and functional imaging in headache.

The journal of headache and pain 20060901

Migraine - a suitable case for treatment?

Neuropsychiatric disease and treatment 20060901

Rizatriptan in the treatment of migraine.

Neuropsychiatric disease and treatment 20060901

The use of combination therapies in the acute management of migraine.

Neuropsychiatric disease and treatment 20060901

Comparative sensitivity of stopwatch methodology and conventional pain assessment measures for detecting early response to triptans in migraine: results of a randomized, open-label pilot study.

Clinical therapeutics 20060801

Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study.

Cephalalgia : an international journal of headache 20060701

Development and validation of a specific stability indicating high performance liquid chromatographic method for rizatriptan benzoate.

Journal of pharmaceutical and biomedical analysis 20060616

Efficacy of Rizatriptan 10 mg administered early in a migraine attack.

Headache 20060601

Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.

Clinical therapeutics 20060601

[Triptanes in the treatment of migraine. A review based on three Cochrane reviews].

Ugeskrift for laeger 20060508

Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches.

Journal of managed care pharmacy : JMCP 20060401

How effectively do rizatriptan and nontriptan drugs restore functional ability after acute migraine?

Nature clinical practice. Neurology 20060401

Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.

Cephalalgia : an international journal of headache 20060301

Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders.

Cephalalgia : an international journal of headache 20060301

Company reference estimates for productivity loss due to migraine and productivity gains using rizatriptan 10 mg in Germany.

International journal of clinical practice 20060301

Pharmacokinetic profile of rizatriptan 10-mg tablet and 10-mg orally disintegrating tablet administered with or without water in healthy subjects: an open-label, randomized, single-dose, 3-period crossover study.

Journal of clinical pharmacology 20060201

Effects of 5-HT1B/1D receptor agonist rizatriptan on cerebral blood flow and blood volume in normal circulation.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20060101

Determination of rizatriptan in human plasma by liquid chromatographic-eletrospray tandem mass spectrometry: application to a pharmacokinetic study.

Biomedical chromatography : BMC 20060101

Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study.

Medical science monitor : international medical journal of experimental and clinical research 20060101

[Medical treatment of migraine attacks in the child].

Revue de l'infirmiere 20060101

Renal infarction during the use of rizatriptan and zolmitriptan: two case reports.

Clinical toxicology (Philadelphia, Pa.) 20060101

Eletriptan: a review of its use in the acute treatment of migraine.

Drugs 20060101

[Clinical use of triptans in the management of migraine].

CNS drugs 20060101

Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.

Headache 20060101

Evaluation of disintegrating time of rapidly disintegrating tablets by a paddle method.

Pharmaceutical development and technology 20060101

Using patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapy.

American journal of therapeutics 20060101

Spotlight on eletriptan in migraine.

CNS drugs 20060101

A comparative study on the cost of new antibiotics and drugs of other therapeutic categories.

PloS one 20060101

Clinical efficacy of rizatriptan for patients with migraine: efficacy of drug therapy for migraine accompanied by tension headache-like symptoms, focusing on neck stiffness.

The journal of headache and pain 20051201

Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.

Headache 20051001

The use of multiattribute decision models in evaluating triptan treatment options in migraine.

Journal of neurology 20050901

Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.

Clinical science (London, England : 1979) 20050901

Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004.

Cephalalgia : an international journal of headache 20050901

Rizatriptan in migraine.

Expert review of neurotherapeutics 20050901

Symptomatic treatment of migraine in children: a systematic review of medication trials.

Pediatrics 20050801

Multiple attack study on the available triptans in Italy versus placebo.

European journal of neurology 20050701

Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat.

Journal of managed care pharmacy : JMCP 20050601

Prediction of genotoxicity of chemical compounds by statistical learning methods.

Chemical research in toxicology 20050601

The treatment of pediatric migraine.

Pediatric annals 20050601

Triptans induce vasoconstriction of human arteries and veins from the thoracic wall.

Journal of cardiovascular pharmacology 20050501

Anti-migraine action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors.

Pain 20050501

Rizatriptan does not change cerebral blood flow velocity during migraine attacks.

Brain research bulletin 20050430

[Economic evaluation of acute migraine attack treatment with triptans in Spain].

Neurologia (Barcelona, Spain) 20050401

Pediatric migraine: recognition and treatment.

The Journal of the American Osteopathic Association 20050401

Eletriptan review.

Expert opinion on pharmacotherapy 20050401

How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.

Current medical research and opinion 20050301

Use of a structured migraine diary improves patient and physician communication about migraine disability and treatment outcomes.

International journal of clinical practice 20050301

[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties.

Naunyn-Schmiedeberg's archives of pharmacology 20050301

Triptan nonresponder studies: implications for clinical practice.

Headache 20050201

Correlation between lipophilicity and triptan outcomes.

Headache 20050101

Intranasal absorption of rizatriptan--in vivo pharmacokinetics and bioavailability study in humans.

Die Pharmazie 20050101

Oral serotonin receptor agonists: a review of their cost effectiveness in migraine.

PharmacoEconomics 20050101

Defining response in migraine: which endpoints are important?

European neurology 20050101

Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.

CNS drugs 20050101

Effects on productivity and quality of life of rizatriptan for acute migraine: a workplace study.

Headache 20050101

Evaluation of the bioequivalence and pharmacokinetics of two formulations of rizatriptan after single oral administration in healthy volunteers.

Arzneimittel-Forschung 20050101

Part III: the convenience of, and patient preference for, zolmitriptan orally disintegrating tablet.

Current medical research and opinion 20050101

An economic evaluation of rizatriptan in the treatment of migraine.

PharmacoEconomics 20050101

Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.

PharmacoEconomics 20050101

Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society.

Neurology 20041228

[Migraine].

Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege 20041201

The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.

Current medical research and opinion 20041101

Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.

Headache 20041001

Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.

Headache 20041001

Evaluating triptan usage: a rebuttal.

Headache 20041001

TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management.

Acta neurologica Scandinavica 20040901

Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).

Clinical therapeutics 20040901

[Meta-analysis of triptan treatment in migraine].

No to shinkei = Brain and nerve 20040901

[Side effects of triptans].

No to shinkei = Brain and nerve 20040901

[It's possible to influence prescriptions patterns by producer-independent information].

Lakartidningen 20040819

Meta-analysis of oral triptans.

Cephalalgia : an international journal of headache 20040801

Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.

Naunyn-Schmiedeberg's archives of pharmacology 20040701

Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets.

Cephalalgia : an international journal of headache 20040701

Liquid chromatographic method for the determination of rizatriptan in human plasma.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040605

Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms.

Cephalalgia : an international journal of headache 20040601

Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.

Cephalalgia : an international journal of headache 20040601

Migraine headache.

Clinical evidence 20040601

Fast onset medications through thermally generated aerosols.

The Journal of pharmacology and experimental therapeutics 20040501

Cost effectiveness of oral triptan therapy: a trans-national comparison based on a meta-analysis of randomised controlled trials.

Current medical research and opinion 20040501

[Rizatriptan (Maxalt), a new entity of triptan for migraine: pharmacology and therapeutic relevance].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20040401

Cost considerations of acute migraine treatment.

Headache 20040301

A review of rizatriptan, a quick and consistent 5-HT1B/1D agonist for the acute treatment of migraine.

Expert opinion on pharmacotherapy 20040301

[Recent progress in therapy for migraine headache].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20040210

Evaluating triptan usage.

Headache 20040201

Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.

Pharmacoepidemiology and drug safety 20040201

Neuronal expression and regulation of CGRP promoter activity following viral gene transfer into cultured trigeminal ganglia neurons.

Brain research 20040130

CNS effects of sumatriptan and rizatriptan.

Cephalalgia : an international journal of headache 20040101

Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.

Annals of neurology 20040101

Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and model.

Journal of occupational and environmental medicine 20040101

Acute treatment of migraine. Breaking the paradigm of monotherapy.

BMC neurology 20040101

Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.

Headache 20040101

Early treatment of migraine with rizatriptan: a placebo-controlled study.

Headache 20040101

Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine.

BMC neurology 20040101

Efficacy of quality criteria to identify potentially harmful information: a cross-sectional survey of complementary and alternative medicine web sites.

Journal of medical Internet research 20040101

[Treatment of migraine].

Medicinski arhiv 20040101

[Modern migraine therapy].

Krankenpflege Journal 20040101

[Migraine therapy--rapid and effective].

Krankenpflege Journal 20040101

Migraine headache.

Clinical evidence 20031201

[It impairs quality of life and work time. Migraine therapy should not be left to the patients!].

MMW Fortschritte der Medizin 20031127

An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug.

British journal of clinical pharmacology 20031101

Triptans for treatment of acute pediatric migraine: a systematic literature review.

Pediatric neurology 20031101

Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting.

International journal of clinical practice 20031101

Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine.

Clinical therapeutics 20031101

Investigation of the effects of naratriptan, rizatriptan, and sumatriptan on jugular venous oxygen saturation in anesthetized pigs: implications for their mechanism of acute antimigraine action.

The Journal of pharmacology and experimental therapeutics 20031001

Rizatriptan RPD for severe migraine in the emergency department--a multicenter study.

The Journal of emergency medicine 20031001

Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein.

Drug metabolism and disposition: the biological fate of chemicals 20030701

Migraine treatment patterns and patient satisfaction with prior therapy: a substudy of a multicenter trial of rizatriptan effectiveness.

Clinical therapeutics 20030701

[Highly selective beginning. Associated symptoms and side effects in retrospect].

MMW Fortschritte der Medizin 20030526

Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans.

Headache 20030401

Real-world experiences in migraine therapy with rizatriptan.

Headache 20030301

Safety profile of the triptans.

Expert opinion on drug safety 20030301

Migraine: pathophysiology, pharmacology, treatment and future trends.

Current vascular pharmacology 20030301

[New therapeutic recommendations for severe migraine. High beginning dosage rather than slow dosage increase].

MMW Fortschritte der Medizin 20030130

Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.

European neurology 20030101

Pharmacological approaches to migraine.

Journal of neural transmission. Supplementum 20030101

Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients.

Headache 20030101

Almotriptan versus rizatriptan in patients with migraine in Spain.

Headache 20030101

Migraine: diagnosis and management.

Internal medicine journal 20030101

Newer formulations of the triptans: advances in migraine management.

Drugs 20030101

Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours.

Journal of managed care pharmacy : JMCP 20030101

Endothelium-dependent relaxant responses to selective 5-HT(1B/1D) receptor agonists in the isolated middle cerebral artery of the rat.

Journal of vascular research 20030101

Current perspectives on effective migraine treatments: are small clinical differences important for patients?

Drugs of today (Barcelona, Spain : 1998) 20030101

[Treatment of migraine: an update].

Revue medicale de la Suisse romande 20030101

[Suppressing effect of the serotonin 5HT1B/D receptor agonist rizatriptan on calcitonin gene-related peptide (CGRP) concentration in migraine attacks].

Neurologia i neurochirurgia polska 20030101

[Satisfaction and recovery of normal activity with rizatriptan 10 mg. Results from the open, prospective, observational 4M study].

Neurologia (Barcelona, Spain) 20021201

[New onset headache. Which patients should be sent for CT imaging?].

MMW Fortschritte der Medizin 20021024

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

Cephalalgia : an international journal of headache 20021001

Sum of Pain Intensity Differences (SPID) in migraine trials. A comment based on four rizatriptan trials.

Cephalalgia : an international journal of headache 20021001

Determinants of migraine-specific quality of life.

Cephalalgia : an international journal of headache 20021001

Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data.

Headache 20021001

Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine.

Journal of medicinal chemistry 20020926

Comparison of rizatriptan and other triptans on stringent measures of efficacy.

Neurology 20020910

Comparison of rizatriptan and other triptans on stringent measures of efficacy.

Neurology 20020910

Rizatriptan 5mg is not efficacious for migraine in adolescents.

Headache 20020901

The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects.

British journal of clinical pharmacology 20020701

Mechanisms of action of the 5-HT1B/1D receptor agonists.

Archives of neurology 20020701

Pharmacological treatments for acute migraine: quantitative systematic review.

Pain 20020601

Gateways to Clinical Trials. June 2002.

Methods and findings in experimental and clinical pharmacology 20020601

[New meta-analysis of triptanes. Concrete help, so the choice doesn't become overwhelming].

MMW Fortschritte der Medizin 20020506

[Good ruler for assessing effectiveness. Pain free with only one tablet].

MMW Fortschritte der Medizin 20020506

[Controlling migraine with highly effective triptanes. Lowers rate of drug use].

MMW Fortschritte der Medizin 20020506

CNS effects of sumatriptan and rizatriptan in healthy female volunteers.

Cephalalgia : an international journal of headache 20020501

Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.

Cephalalgia : an international journal of headache 20020501

Gateways to Clinical Trials.

Methods and findings in experimental and clinical pharmacology 20020401

Molecular cloning and expression of the porcine trigeminal ganglion cDNA encoding a 5-ht(1F) receptor.

European journal of pharmacology 20020201

Migraine: diagnosis, management, and new treatment options.

The American journal of managed care 20020201

Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.

Headache 20020201

[Treatment of migraine in patients with hypertension and ischemic heart disease].

Ideggyogyaszati szemle 20020120

Tripstar: a comprehensive patient-based approach to compare triptans.

Headache 20020101

Treatment of migraine with rizatriptan: when to take the medication.

Headache 20020101

Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.

Headache 20020101

Rizatriptan: an update of its use in the management of migraine.

Drugs 20020101

Spotlight on rizatriptan in migraine.

CNS drugs 20020101

Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials.

European neurology 20020101

Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20020101

An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.

Proceedings of the Western Pharmacology Society 20020101

[Therapy of an acute migraine attack. Uniform patient vote for rizatriptan].

MMW Fortschritte der Medizin 20011122

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.

Lancet (London, England) 20011117

Clinical features of withdrawal headache following overuse of triptans and other headache drugs.

Neurology 20011113

[Cost effectiveness of treatment with triptanes in Spain].

Revista de neurologia 20011101

Cluster headache without autonomic symptoms?

Cephalalgia : an international journal of headache 20011101

Evidence-based migraine therapy.

Cephalalgia : an international journal of headache 20011101

Comparison of rizatriptan and other triptans on stringent measures of efficacy.

Neurology 20011023

Pharmacokinetics of rizatriptan in healthy elderly subjects.

International journal of clinical pharmacology and therapeutics 20011001

Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons.

International journal of clinical practice 20011001

Migraine MLT-down: an unusual presentation of migraine in patients with aspartame-triggered headaches.

Headache 20011001

Advances in pharmacological treatment of migraine.

Expert opinion on investigational drugs 20011001

Triptans are all different.

Archives of neurology 20010901

What matters is not the differences between triptans, but the differences between patients.

Archives of neurology 20010901

Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.

Headache 20010901

Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.

Headache 20010901

Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug.

Arquivos de neuro-psiquiatria 20010901

A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients.

Pain 20010801

The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.

British journal of pharmacology 20010801

Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans).

Archives of neurology 20010701

Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.

British journal of clinical pharmacology 20010701

Safety and rational use of the triptans.

The Medical clinics of North America 20010701

Effect of rizatriptan in the spectrum of headache.

Headache 20010601

Current options for the prevention and treatment of migraine.

Clinical therapeutics 20010601

Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.

Clinical therapeutics 20010601

Long-term efficacy and tolerability of rizatriptan wafers in migraine.

MedGenMed : Medscape general medicine 20010601

[Current topics: expectation for new triptans].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20010410

Efficacy and tolerability of rizatriptan 10 mg in migraine: experience with 70 527 patient episodes.

Headache 20010301

Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials.

Cephalalgia : an international journal of headache 20010301

Acute treatment of migraine and the role of triptans.

Current neurology and neuroscience reports 20010301

A systematic review of the use of triptans in acute migraine.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20010201

Rizatriptan wafer--sublingual vs. placebo at the onset of acute migraine.

Cephalalgia : an international journal of headache 20010201

New abortive agents for the treatment of migraine.

Advances in internal medicine 20010101

Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review.

Clinical pharmacokinetics 20010101

Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.

European neurology 20010101

Rizatriptan for acute migraine.

The Cochrane database of systematic reviews 20010101

Triptans in the treatment of basilar migraine and migraine with prolonged aura.

Headache 20010101

Sumatriptan: pharmacological basis and clinical results.

Current medical research and opinion 20010101

Rizatriptan: pharmacological differences from sumatriptan and clinical results.

Current medical research and opinion 20010101

Comparative aspects of triptans in treating migraine.

Clinical cornerstone 20010101

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.

Drugs 20001201

A double-blind, placebo-controlled evaluation of the effect of oral doses of rizatriptan 10 mg on oral contraceptive pharmacokinetics in healthy female volunteers.

Journal of clinical pharmacology 20000301

Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.

Acta neurologica Belgica 19990601

Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.

European journal of pharmacology 19990305

N-Methyl-5-tert-butyltryptamine: A novel, highly potent 5-HT1D receptor agonist.

Journal of medicinal chemistry 19990211

Coronary side-effect potential of current and prospective antimigraine drugs.

Circulation 19980707

Pharmacological analysis of the haemodynamic effects of 5-HT1B/D receptor agonists in the normotensive rat.

British journal of pharmacology 19980101

Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group.

Headache 19980101